What is HCAT (HCAT) stock price today?

HCAT (HCAT) is currently trading at $1.69, down 1.17% today.

What is HCAT P/E ratio?

HCAT's P/E ratio is -0.54. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is HCAT return on equity (ROE)?

HCAT's return on equity (ROE) is -72.36%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is HCAT's market cap?

HCAT has a market capitalization of $124.88M.

NASDAQ · Medical - Healthcare Information Services

HCAT (HCAT) Stock

$1.69 -1.17% NASDAQ: HCAT Healthcare

Valuation

Metric	Value
Price	$1.69
Market Cap	$124.88M
P/E Ratio	-0.54
P/B Ratio	0.41
P/S Ratio	0.42
EPS (TTM)	$-2.55
52-Week High	$4.13
52-Week Low	$0.95
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-72.36%
ROA	-35.39%
ROCE	-14.63%
Gross Margin	-11.58%
Operating Margin	-11.58%
Net Margin	-87.69%
Debt/Equity	1.23
Current Ratio	1.88

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$242.0M	$276.0M	$296.0M	$307.0M	$311.0M
Operating Profit	$-144.0M	$-140.0M	$-127.0M	$-70.0M	$-36.0M
Net Profit	$-153.0M	$-137.0M	$-118.0M	$-70.0M	$-178.0M
EPS	$-3.23	$-2.54	$-2.09	$-1.15	$-2.55
Op Margin	-59.4%	-50.7%	-42.9%	-22.8%	-11.6%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$832.0M	$752.0M	$702.0M	$859.0M	$503.0M
Total Liabilities	$310.0M	$327.0M	$335.0M	$494.0M	$257.0M
Cash	$193.0M	$116.0M	$106.0M	$250.0M	$51.0M
Borrowings	$205.0M	$248.0M	$249.0M	$402.0M	$171.0M

Latest News

3 Reasons to Sell HCAT and 1 Stock to Buy Instead StockStory · Jul 15, 2026 3 Small-Cap Stocks We Think Twice About StockStory · Jul 13, 2026 monday.com, Intuit, and Health Catalyst Stocks Trade Down, What You Need To Know StockStory · Jul 8, 2026 3 Stocks Under $10 We’re Skeptical Of StockStory · Jul 3, 2026 Health Catalyst, PubMatic, and PTC Stocks Trade Up, What You Need To Know StockStory · Jul 1, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-23.0M	$-35.0M	$-33.0M	$15.0M	$1.0M
Investing Cash Flow	$-158.0M	$-56.0M	$6.0M	$-39.0M	$35.0M
Financing Cash Flow	$19.0M	$-3.0M	$3.0M	$-2.0M	$-5.0M
Net Cash Flow	$101.0M	$-77.0M	$-10.0M	$143.0M	$-199.0M
Free Cash Flow	$-42.0M	$-53.0M	$-47.0M	$-2.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	16.47
FCF Yield	7.21%
Quick Ratio	1.69
Interest Coverage	-2.25
Return 1Y	-40.67%
Return 3Y	-81.38%
Return 5Y	-95.82%

Ownership

Insiders Held5.15%

Institutions Held78.11%

Institutions Float Held82.35%

Institutional Holder	Shares	Report Date
First Light Asset Management, LLC	12,878,700	2026-03-31
Cdc Financial, Inc.	6,307,054	2026-03-31
Blackrock Inc.	5,138,022	2026-03-31
Whetstone Capital Advisors, LLC	4,268,141	2026-03-31
Nepsis, Inc.	2,976,187	2026-06-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CRBU	$1.60	+3.23%	-1.25	$158.69M	0.00%
ENTA	$14.09	+4.29%	-6.04	$409.71M	0.00%
HSDT	$2.08	-0.48%	-1.25	$121.44M	0.00%
NNOX	$0.76	-2.81%	-1.56	$53.16M	0.00%
OBIO	$4.95	+1.02%	-5.00	$296.41M	0.00%

About HCAT

HCAT is led by CEO Benjamin Albert, employs 1,500 people, headquartered in US, publicly traded since 2019.

HCAT stock trades at $1.69 with a market capitalization of $124.88M. The stock is valued at a price-to-earnings (P/E) ratio of -0.54, price-to-book of 0.41, price-to-sales of 0.42. Over the past 52 weeks the stock has ranged between $0.95 and $4.13, and currently trades 59.0% below its 52-week high.

On profitability, HCAT generates a return on equity (ROE) of -72.36%, return on capital employed of -14.63%, an operating margin of -11.58%, a net profit margin of -87.69%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides